BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $67,000 | -63.0% | 449 | -63.9% | 0.00% | – |
Q2 2022 | $181,000 | +75.7% | 1,243 | +42.1% | 0.00% | – |
Q1 2022 | $103,000 | -14.9% | 875 | -0.5% | 0.00% | – |
Q4 2021 | $121,000 | -90.3% | 879 | -90.2% | 0.00% | -100.0% |
Q3 2021 | $1,249,000 | +1369.4% | 8,996 | +920.0% | 0.00% | – |
Q2 2021 | $85,000 | +1114.3% | 882 | +732.1% | 0.00% | – |
Q1 2021 | $7,000 | -86.8% | 106 | -82.9% | 0.00% | – |
Q4 2020 | $53,000 | – | 620 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |